216 related articles for article (PubMed ID: 20071306)
1. [Neoadjuvant radiochemotherapy in the treatment of locally advanced rectal tumors].
Rápolti E; Szigeti A; Farkas R; Bellyei S; Boronkai A; Papp A; Gömöri E; Horváth OP; Mangel L
Magy Onkol; 2009 Dec; 53(4):345-9. PubMed ID: 20071306
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
6. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
8. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
[TBL] [Abstract][Full Text] [Related]
9. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
10. [Exploration on neoadjuvant chemoradiation in the treatment for locally advanced low rectal cancer].
Yu BM; Zhang M; Peng LH; Bian GW; Wu WQ; Chen LW; Fu J; Fei CS
Zhonghua Wai Ke Za Zhi; 2009 Oct; 47(20):1540-3. PubMed ID: 20092741
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
Mohiuddin M; Winter K; Mitchell E; Hanna N; Yuen A; Nichols C; Shane R; Hayostek C; Willett C;
J Clin Oncol; 2006 Feb; 24(4):650-5. PubMed ID: 16446336
[TBL] [Abstract][Full Text] [Related]
14. [Study on the relationship between tumor regression grade and lymph node regression grade].
Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
[TBL] [Abstract][Full Text] [Related]
15. Preoperative radio-chemotherapy treatment in locally advanced rectal carcinoma. Results of 8-year follow-up.
Mermershtain W; Gluzman A; Gusakova I; Walfish S; Cohen Y; Ariad S
Onkologie; 2005 May; 28(5):267-9. PubMed ID: 15867483
[TBL] [Abstract][Full Text] [Related]
16. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.
Rödel C; Grabenbauer GG; Matzel KE; Schick C; Fietkau R; Papadopoulos T; Martus P; Hohenberger W; Sauer R
Dis Colon Rectum; 2000 Mar; 43(3):312-9. PubMed ID: 10733111
[TBL] [Abstract][Full Text] [Related]
17. Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity.
Schaffer M; Thoma M; Wilkowski R; Schaffer P; Dühmke E
Onkologie; 2002 Aug; 25(4):352-6. PubMed ID: 12232487
[TBL] [Abstract][Full Text] [Related]
18. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
[TBL] [Abstract][Full Text] [Related]
19. [The safety and efficacy of radical surgery after modified total neoadjuvant therapy for locally advanced rectal cancer].
Zhang L; Yu L; Wu YL; Zhang QQ; Shen SH; Li DD; Fang H; Yang L; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):501-506. PubMed ID: 32575948
[No Abstract] [Full Text] [Related]
20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
